Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

(Source: Nasdaq/GlobeNewswire, Reuters, TipRanks, Finviz, company filings.) Company Overview: Rare Disease Focus and Pipeline Progress Quoin Pharmaceuticals Ltd. is a clinical-stage biotech specializing in rare dermatological diseases. Headquartered in Ashburn, VA, Quoin’s mission is to deliver the first approved therapies
Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Company Overview Protagonist Therapeutics is a clinical-stage biopharma company leveraging peptide technology to create new medicines for rare hematologic conditions and prevalent immunological diseases protagonist-inc.com. Founded in 2008, Protagonist has built its identity around engineered peptide drugs – a niche
Bitcoin $125K, Gold $4K, Silver $50 – Inside 2025’s Epic Safe-Haven Showdown

Bitcoin $125K, Gold $4K, Silver $50 – Inside 2025’s Epic Safe-Haven Showdown

Current Market Snapshot (Oct 2025) As of mid-October 2025, both cryptocurrencies and precious metals are trading near historic highs after an extraordinary rally this year. Bitcoin – the leading cryptocurrency – spiked above $125,000 in early October, marking a new record high ts2.tech. It
Go toTop